Clinical Trial Update: Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating remimazolam versus propofol as induction agents in morbid obesity patients undergoing anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• PROPOFOL (Propofol)
• Remimazolam (remimazolam)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Remimazolam, Desflurane | Phase 4 | Status: UNKNOWN